Broad Medicare Formularies Would Negatively Impact Rx Industry – PCMA

Strict formulary requirements imposed on plan sponsors under the Medicare prescription drug benefit would be self-defeating for pharmaceutical manufacturers, Pharmaceutical Care Management Association CEO Mark Merritt argued Oct. 25

More from Archive

More from Pink Sheet